Citadel Advisors’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-600
Closed -$51.6K 15033
2024
Q4
$51.6K Buy
+600
New +$55.4K ﹤0.01% 12362
2024
Q1
Sell
-2,200
Closed -$191K 15030
2023
Q4
$191K Buy
+2,200
New +$182K ﹤0.01% 10027
2023
Q3
Sell
-100
Closed -$8.5K 14698
2023
Q2
$8.5K Sell
100
-600
-86% -$51.2K ﹤0.01% 13316
2023
Q1
$58.4K Buy
700
+400
+133% +$33.1K ﹤0.01% 11956
2022
Q4
$25.5K Buy
+300
New +$24.7K ﹤0.01% 12927

Other funds holding IXJ

Citadel Advisors's IXJ Position: Q2 2026 in Review

Citadel Advisors sold out of iShares Global Healthcare ETF (IXJ) in Q2 2026, closing a stake of 56,307 shares — an estimated $5.3M sold.

Citadel Advisors first reported a position in IXJ in Q1 2014 and held it in 33 quarters. The position peaked at $15.5M in Q3 2015. 301 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Citadel Advisors reported no remaining iShares Global Healthcare ETF position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 56,307 iShares Global Healthcare ETF shares in Q2 2026, an estimated $5.3M.
  • Citadel Advisors first reported a position in iShares Global Healthcare ETF in Q1 2014 and held it in 33 quarters.
  • Citadel Advisors's iShares Global Healthcare ETF position peaked at $15.5M in Q3 2015.
  • 301 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.